Lv4
720 积分 2023-08-30 加入
Orforglipron, an Oral Small-Molecule GLP-1 Receptor Agonist for Obesity Treatment
3天前
已完结
Macro and micro sleep architecture and cognitive performance in older adults
4天前
已完结
Treatment for obstructive sleep apnoea and cardiovascular diseases: are we aiming at the wrong target?
5天前
已完结
Tirzepatide for the Treatment of Obstructive Sleep Apnea and Obesity
6天前
已完结
Treatment for obstructive sleep apnoea and cardiovascular diseases: are we aiming at the wrong target?
6天前
已完结
Weekly Journal Scan: tirzepatide SURMOUNTs obesity-related obstructive sleep apnoea
7天前
已完结
Tirzepatide: A Breakthrough Therapy for Obstructive Sleep Apnea and Metabolic Dysfunction
7天前
已完结
Tirzepatide’s role in targeting adipose tissue macrophages to reduce obesity-related inflammation and improve insulin resistance
7天前
已完结
Entering a New Era in Sleep-Apnea Treatment
7天前
已完结
Tirzepatide for the Treatment of Obstructive Sleep Apnea and Obesity
14天前
已关闭
皖公网安备34019202002308
